Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on May 14, 2025

Materials, Data, Landscapes, Space, and Wellbeing: Politecnico di Milano research supporting 7 Projects at the Biennale Architettura 2025
MILAN, May 14, 2025 (GLOBE NEWSWIRE) -- At the 19th International Architecture Exhibition – La Biennale di Venezia, taking place 10 May-23 November 2025, Politecnico di Milano will support seven projects addressing the challenges of contemporary …

Best Creatine For Men 2025: Top Athlete-Tested Supplements for Muscle Growth, Strength & Recovery
Glasgow, May 14, 2025 (GLOBE NEWSWIRE) -- Introduction In simple words, creatine is a substance that occurs naturally in our muscle cells. It helps our muscles produce enough energy while we perform intense activities such as heavyweight lifting or a high …

Best Debt Relief Programs for 2025 to Help You Get Out of Debt in USA
DALLAS, May 14, 2025 (GLOBE NEWSWIRE) -- Payday Ventures, a leading provider of financial solutions in the United States, is proud to introduce new and improved Debt Relief Programs for 2025 through its trusted brand, Viva Debt Help. As more Americans …

Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical Stage Company Developing Fibrin-targeting Immunotherapies for Neurodegenerative Diseases
Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic Macular Edema (DME), as well as support development of a …

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s PK …

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
Salt Lake City, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that …

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations Early dose-escalation data from Phase 1 CARDINAL study of TERN-701 in CML patients showed …

BSTR Miner completes a new round of strategic financing, empowering global miners to increase their income with an innovative cloud mining model
Washington, D.C., May 14, 2025 (GLOBE NEWSWIRE) -- BSTR Miner, the world's leading compliant cloud mining platform, announced today that it has completed strategic financing led by well-known investment institutions Grayscale and Goldman Sachs. This round …

New opportunities for XRP and DOGE enthusiasts: How to earn passive income every day with XRP and DOGE.
Miami, FL, May 14, 2025 (GLOBE NEWSWIRE) -- In today's crypto market, more and more investors are looking for ways to make stable profits without frequent trading. SAVVY MINING By 2025, cloud mining has emerged as a low-intervention, high-potential passive …

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories
SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into an …

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, …

Robex Kiniero Project on Track for First Gold in Q4
HIGHLIGHTS: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget - first gold pour on track for Q4 CY25. Project remains LTI free (lost time injury). Phase 1 grade control drilling at Mansounia commenced on 18 March 2025 …

A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices in Caesarean section (C-section) recovery has identified …

Technip Energies appoints Marco Tiziano Barone as Chief Legal Officer
Technip Energies announces the appointment of Marco Tiziano Barone as Chief Legal Officer and member of the Group Executive Committee. In this role, he will oversee the Group’s Legal, Contracts and Compliance function. He succeeds Michael McGuinty, who has …

OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration
VILNIUS, Lithuania, May 14, 2025 – Leading web intelligence collection platform Oxylabs announces registration start for the year's main event. OxyCon 2025, the annual free conference uniting industry experts from all over the world, is set for October 1. …

Technip Energies nomme Marco Tiziano Barone au poste de Directeur Juridique
Technip Energies annonce la nomination de Marco Tiziano Barone en tant que Directeur Juridique et membre du Comité Exécutif du Groupe. A ce titre, il supervisera la fonction Juridique, Contrats et Conformité du Groupe. Il succède à Michael McGuinty, qui a …

NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference
NAARDEN, The Netherlands and MIAMI, May 14, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three patients in the 550 mg twice daily cohort in the ongoing …

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …

Entrée Resources Announces Drill Results from Hugo North Extension, Including 260 Metres Grading 4.45% CuEq
VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) is pleased to provide analytical results for one surface diamond drill hole (“DDH”) and six underground DDHs completed …